Metabolic effects of androgenotherapy: impact on glucolipotoxicity in patients with type 2 diabetes mellitus and visceral obesity

• Olga A. Rozhdestvenskaya

Abstract

Testosterone replacement therapy in patients with type 2 diabetes mellitus, visceral obesity and androgenotherapy improves metabolic characteristics of carbohydrate and lipid metabolism, and elimination of state glucolipotoxicity.

Keywords:type 2 diabetes mellitus, glucolipotoxicity, testosterone deficiency, androgenotherapy

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)